Invesco Ltd. Spectrum Pharmaceuticals Inc Transaction History

Invesco Ltd.

  • $499 Billion
  • Q3 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.7 - $1.4 $41,121 - $82,243
-58,745 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$0.63 - $1.59 $536,863 - $1.35 Million
-852,164 Reduced 93.55%
58,745 $76,000
Q4 2021

Feb 14, 2022
BUY
$1.27 - $2.42 $18,331 - $34,930
14,434 Added 1.61%
910,909 $1.16 Million
Q3 2021

Nov 15, 2021
BUY
$2.15 - $3.82 $13,185 - $23,428
6,133 Added 0.69%
896,475 $1.96 Million
Q2 2021

Aug 17, 2021
BUY
$2.89 - $4.45 $195,901 - $301,647
67,786 Added 8.24%
890,342 $3.34 Million
Q1 2021

May 17, 2021
SELL
$2.9 - $4.09 $150,678 - $212,508
-51,958 Reduced 5.94%
822,556 $2.68 Million
Q4 2020

Feb 16, 2021
BUY
$3.38 - $5.14 $66,856 - $101,669
19,780 Added 2.31%
874,514 $2.98 Million
Q3 2020

Nov 16, 2020
BUY
$2.99 - $4.9 $387,378 - $634,834
129,558 Added 17.87%
854,734 $3.49 Million
Q2 2020

Aug 14, 2020
SELL
$2.11 - $3.38 $16,772 - $26,867
-7,949 Reduced 1.08%
725,176 $2.45 Million
Q1 2020

May 15, 2020
BUY
$1.83 - $3.45 $135,251 - $254,982
73,908 Added 11.21%
733,125 $1.71 Million
Q4 2019

Feb 14, 2020
SELL
$3.5 - $10.35 $36,701 - $108,530
-10,486 Reduced 1.57%
659,217 $2.4 Million
Q3 2019

Nov 14, 2019
SELL
$7.03 - $9.7 $504,718 - $696,411
-71,795 Reduced 9.68%
669,703 $5.56 Million
Q2 2019

Aug 14, 2019
SELL
$7.36 - $11.26 $1.91 Million - $2.92 Million
-259,096 Reduced 25.89%
741,498 $6.38 Million
Q1 2019

May 15, 2019
SELL
$9.08 - $11.84 $852,493 - $1.11 Million
-93,887 Reduced 8.58%
1,000,594 $10.7 Million
Q4 2018

Feb 14, 2019
BUY
$6.39 - $16.99 $6.99 Million - $18.6 Million
1,094,481 New
1,094,481 $9.58 Million

Others Institutions Holding SPPI

# of Institutions
1
Shares Held
115K
Call Options Held
0
Put Options Held
0
View Full List

About SPECTRUM PHARMACEUTICALS INC

SPPI Quotes by TradingView
  • Ticker SPPI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 188,164,000
  • Description
  • Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...
More about SPPI
Track This Portfolio

Track Invesco Ltd. Portfolio

Follow Invesco Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email